• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION UPHOLD VAGINAL SUPPORT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION UPHOLD VAGINAL SUPPORT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN Back to Search Results
Model Number M0068317080
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Incontinence (1928); Pain (1994); Dyspareunia (4505); Insufficient Information (4580)
Event Date 06/19/2020
Event Type  Injury  
Manufacturer Narrative
Patient identifier: (b)(6).The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The upn provided was chosen as a representative upn to capture the implanted device.The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an upsylon y-mesh was implanted into the patient on (b)(6) 2011.The patient experienced complications and nonsurgical treatment.Patient symptoms include: vaginal pain; pelvic pain; groin pain; thigh pain; painful intercourse; recurrent incontinence; damage.Nonsurgical treatments: on (b)(6) 2020 the patient commenced pain medication: amitriptyline for the treatment of: pain in pelvic floor.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced physiotherapy treatment: pelvic floor exercises to relieve pain.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced topical treatment (including oestrogen cream): topical endep cream for the treatment of: pain relief.Treatment duration: 11 months.On (b)(6) 2021 the patient commenced injections (not associated with surgical treatment): steroid for the treatment of: pain relief for groin.Treatment duration: 1 injection.
 
Event Description
It was reported to boston scientific corporation that an upsylon y-mesh was implanted into the patient on october 18, 2011.The patient experienced complications and nonsurgical treatment.Patient symptoms include: vaginal pain; pelvic pain; groin pain; thigh pain; painful intercourse; recurrent incontinence; damage nonsurgical treatments: on (b)(6) 2020 the patient commenced pain medication: amitriptyline for the treatment of: pain in pelvic floor.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced physiotherapy treatment: pelvic floor exercises to relieve pain.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced topical treatment (including oestrogen cream): topical endep cream for the treatment of: pain relief.Treatment duration: 11 months.On (b)(6) 2021 the patient commenced injections (not associated with surgical treatment): steroid for the treatment of: pain relief for groin.Treatment duration: 1 injection.Boston scientific received an additional information on august 11, 2022 as follows: it was reported to boston scientific corporation that an uphold vaginal support system device was implanted into the patient during a sacrospinous colpopexy procedure performed on (b)(6) 2011 for the treatment of rectocele and enterocele.The patient experienced the following complications after the procedure: vaginal pain, pelvic pain, groin pain, thigh pain, painful intercourse, recurrent incontinence, damage.The patient was then required nonsurgical treatments to relieve the symptoms: on (b)(6) 2020 the patient commenced pain medication: amitriptyline for the treatment of: pain in pelvic floor.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced physiotherapy treatment: pelvic floor exercises to relieve pain.Treatment duration: 4 months.On (b)(6) 2020 the patient commenced topical treatment (including oestrogen cream): topical endep cream for the treatment of: pain relief.Treatment duration: 11 months.On (b)(6) 2021 the patient commenced injections (not associated with surgical treatment): steroid for the treatment of: pain relief for groin.Treatment duration: 1 injection.
 
Manufacturer Narrative
Block h2: additional information.Block a1: patient identifier (b)(6) added.Block b5 narrative updated.Block d4 model number, lot number and expiration date updated.Block g1 manufacturing site updated.Block h4 manufacturing date updated.Block b3 date of event: date of event was approximated to (b)(6) 2011, implant procedure date, as no event date was reported.Block e1: this event was reported by the patient's legal representation.The implant surgeon is: (b)(6).Block h6: patient code e1405, e2330 capture the reportable events of dyspareunia and pain impact code f12 and f2303 has been used in the light of this patient had filed a legal claim for the injuries related to the device and the prescribed medications.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device is not available for return; therefore, a device analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UPHOLD VAGINAL SUPPORT SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
FREUDENBERG MEDICAL MIS INC
2301 centennial boulevard
jeffersonville IN 47130
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13052760
MDR Text Key282564277
Report Number3005099803-2021-06782
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K081048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2011
Device Model NumberM0068317080
Device Catalogue Number831-708
Device Lot Number1ML0070603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/17/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient Weight92 KG
-
-